These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 577299

  • 41. Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrile.
    Teychenne PF, Rosin AJ, Plotkin CN, Calne DB.
    Br J Clin Pharmacol; 1980 Jan; 9(1):47-50. PubMed ID: 6101955
    [Abstract] [Full Text] [Related]

  • 42. Paradoxial response to dopaminergic agents in parkinsonism.
    Wiener WJ, Kramer J, Nausieda PA, Klawans HL.
    Arch Neurol; 1978 Jul; 35(7):453-5. PubMed ID: 666596
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Metabolic studies with bromocriptine in patients with idiopathic parkinsonism and Huntington's chorea.
    Kartzinel R, Perlow MD, Carter AC, Chase TN, Calne DB, Shoulson I.
    Trans Am Neurol Assoc; 1976 Jul; 101():53-6. PubMed ID: 141763
    [No Abstract] [Full Text] [Related]

  • 49. Effects of bromocriptine on dopamine turnover with or without levodopa.
    Ogawa N, Asanuma M, Tanaka K, Matsuura K, Iida K, Yamamoto M.
    J Int Med Res; 1996 Jul; 24(3):271-7. PubMed ID: 8725988
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Studies with bromocriptine. Part 1. "On-off" phenomena.
    Kartznel R, Calne DB.
    Neurology; 1976 Jun; 26(6 PT 1):508-10. PubMed ID: 945489
    [Abstract] [Full Text] [Related]

  • 52. Letter: Bromocriptine in parkinsonism.
    Debono AG, Donaldson I, Marsden CD, Parkes JD.
    Lancet; 1975 Nov 15; 2(7942):987-8. PubMed ID: 53479
    [No Abstract] [Full Text] [Related]

  • 53. Bromocriptine in parkinsonism. A long-term study.
    Lees AJ, Haddad S, Shaw KM, Kohout LJ, Stern GM.
    Arch Neurol; 1978 Aug 15; 35(8):503-5. PubMed ID: 666607
    [Abstract] [Full Text] [Related]

  • 54. Comparison of pergolide and bromocriptine therapy in parkinsonism.
    LeWitt PA, Ward CD, Larsen TA, Raphaelson MI, Newman RP, Foster N, Dambrosia JM, Calne DB.
    Neurology; 1983 Aug 15; 33(8):1009-14. PubMed ID: 6348585
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause.
    Figà-Talamanca L, Gualandi C, Di Meo L, Di Battista G, Neri G, Lo Russo F.
    Neurology; 1985 Feb 15; 35(2):258-61. PubMed ID: 3969217
    [Abstract] [Full Text] [Related]

  • 60. Prolactin secretion in Parkinson disease.
    Eisler T, Thorner MO, MacLeod RM, Kaiser DL, Calne DB.
    Neurology; 1981 Oct 15; 31(10):1356-9. PubMed ID: 6810204
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.